Literature DB >> 27145691

Analysis of correlation factors and pregnancy outcomes of hypertensive disorders of pregnancy - a secondary analysis of a random sampling in Beijing, China.

Yu-Chun Zhu1, Hui-Xia Yang1, Yu-Mei Wei1, Wei-Wei Zhu1, Wen-Ying Meng2, Yong-Qing Wang3, Li-Xin Shang4, Zhen-Yu Cai5, Li-Ping Ji6, Yun-Feng Wang7, Ying Sun8, Jia-Xiu Liu9, Li Wei10, Yu-Feng Sun11, Xue-Ying Zhang12, Tian-Xia Luo13, Hai-Xia Chen14, Li-Jun Yu15.   

Abstract

OBJECTIVE: We aimed to assess the prevalence and risk factors for hypertensive disorders and to study the main pregnancy outcomes in the Beijing area of China. STUDY
DESIGN: This study randomly sampled 15 hospitals in Beijing from Jun 2013 to Nov 2013 and evaluated 15 194 deliveries. Logistic regression analysis was used to study the association between risk factors and hypertensive disorders. Pregnancy outcomes included preterm birth, cesarean delivery and small for gestational age (SGA).
RESULTS: The prevalence of hypertensive disorders, preeclampsia (PE) and severe PE was 4.4, 2.7 and 1.8%, respectively. The risk factors for hypertensive disorders and severe PE were maternal body mass index before pregnancy, gestational weight gain (GWG), gestational diabetes and pre-gestational diabetes, and third trimester cholesterol (CHOL) levels. First trimester high-density lipoprotein was a protective factor for severe PE. The incidence of hypertensive disorders increased with maternal age. Preterm delivery, cesarean delivery and small infant size for gestational age were more prevalent in the severe PE group compared with the non-hypertensive group.
CONCLUSIONS: In the Beijing area of China, maternal body mass index before pregnancy, GWG, maternal complications of gestational diabetes and pre-gestational diabetes, and third trimester CHOL levels are risk factors for both hypertensive disorders of pregnancy and severe PE. First trimester high-density lipoprotein is a protective factor for severe PE. Severe preeclampsia leads to a higher incidence of preterm delivery, cesarean delivery and SGA infants.

Entities:  

Keywords:  Hypertension; incidence; outcome; preeclampsia; risk factor

Mesh:

Year:  2016        PMID: 27145691     DOI: 10.1080/14767058.2016.1186161

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  4 in total

1.  Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial.

Authors:  Li Lin; Yuchun Zhu; Boya Li; Huixia Yang
Journal:  Trials       Date:  2018-11-06       Impact factor: 2.279

2.  Association between thyroid hormone parameters during early pregnancy and gestational hypertension: a prospective cohort study.

Authors:  Hua Lai; Zheng-Yu Zhan; Huai Liu
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

3.  Active Management of Labor Process under Smart Medical Model Improves Vaginal Delivery Outcomes of Pregnant Women with Preeclampsia.

Authors:  Siming Xin; Xianxian Liu; Jiusheng Zheng; Hua Lai; Jiao Zhou; Feng Zhang; Xiaoying Wu; Ting Shen; Lin Xu; Xiaoming Zeng
Journal:  J Healthc Eng       Date:  2022-04-07       Impact factor: 3.822

4.  Changes in the live birth profile in Henan, China: A hospital registry-based study.

Authors:  Xiaoli Zhang; Xi Chen; Bingbing Li; Lei Xia; Shan Zhang; Wenjun Ding; Liang Gao; Aiqing Liu; Falin Xu; Ruili Zhang; Shihong Cui; Xiaoyang Wang; Changlian Zhu
Journal:  Birth       Date:  2022-02-20       Impact factor: 3.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.